You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 54436-0112


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 54436-0112

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
TLANDO 112.5MG CAP Verity Pharmaceuticals Inc. 54436-0112-20 120 672.65 5.60542 2024-03-05 - 2026-11-30 FSS
TLANDO 112.5MG CAP Verity Pharmaceuticals Inc. 54436-0112-20 120 556.99 4.64158 2024-03-05 - 2026-11-30 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Market Analysis and Price Projections for the Drug NDC: 54436-0112

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a drug identified by the NDC 54436-0112, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product in the United States. It consists of a labeler code, a product code, and a package code[4].

Identifying the Drug

The NDC 54436-0112 can be broken down as follows:

  • Labeler Code: 54436
  • Product Code: 01
  • Package Code: 12

This NDC identifies a specific drug product, its strength, dosage form, and package size.

Market Context

Prescription Drug Pricing Trends

Prescription drug prices in the United States are significantly higher than in many other high-income countries. According to a report by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. prices for prescription drugs are nearly three times as high as prices in 33 OECD comparison countries[3].

Price Transparency and Reporting

The Oregon Drug Price Transparency Program highlights the variability in drug pricing and the need for transparency. The program requires manufacturers to report price increases and new high-cost drugs, revealing that median price increases for generic drugs were 19.9% and for brand-name drugs were 13.4% in 2022[2].

Price Projections

Historical Pricing Data

To project future prices, it is essential to analyze historical pricing data. For the NDC 54436-0112, one would need to look at past price trends, including any significant increases or decreases. For example, the Oregon report mentioned a generic naproxen with a 2,527% price increase over a decade, illustrating the potential for dramatic price changes[2].

Market Factors Influencing Prices

Several factors influence prescription drug prices:

  • Supply Chain Dynamics: Interactions between pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health insurers, and other entities in the supply chain can significantly impact drug prices[2].
  • Regulatory Environment: Policies such as those implemented by Oregon to enhance price transparency and potential upper payment limits can affect pricing strategies[2].
  • International Comparisons: The gap between U.S. and international drug prices suggests that U.S. prices may continue to be higher due to various market and regulatory factors[3].

Specific Analysis for NDC 54436-0112

Current Pricing

To analyze the current pricing of the drug with NDC 54436-0112, one would need to refer to the FDA's NDC Directory or other pricing databases. These resources provide the most recent pricing information submitted by the labeler[1][4].

Future Price Projections

Given the historical trends and market factors:

  • Short-Term Projections: If the drug is a generic, it might experience moderate price increases, potentially in line with the median increases seen in 2022 (19.9% for generics). For brand-name drugs, the increase could be around 13.4%[2].
  • Long-Term Projections: Considering the widening gap between U.S. and international drug prices, and the potential for regulatory changes aimed at price transparency and affordability, long-term price projections might show a slower rate of increase or even stabilization.

Key Considerations

Regulatory Changes

Proposed changes, such as the adoption of a single NDC format and updates to drug product barcode labeling requirements, could impact the efficiency and accuracy of drug tracking and pricing[5].

Consumer Impact

High drug prices can lead to non-adherence to medication regimens. A significant portion of Americans report not taking their medications as prescribed due to cost, which can have broader health and economic implications[2].

Conclusion

The market analysis and price projections for the drug with NDC 54436-0112 depend on a thorough understanding of historical pricing data, market trends, and regulatory factors. Here are some key points to consider:

  • Historical Pricing: Analyze past price trends for the specific NDC.
  • Market Trends: Consider the broader trends in prescription drug pricing, including supply chain dynamics and regulatory changes.
  • Regulatory Environment: Keep an eye on policies aimed at price transparency and affordability.
  • International Comparisons: Recognize the significant price differences between the U.S. and other countries.

Key Takeaways

  • NDC Importance: The NDC is a critical identifier for drug products, facilitating tracking and pricing.
  • Pricing Trends: U.S. prescription drug prices are significantly higher than in other high-income countries.
  • Regulatory Impact: Policies and regulatory changes can significantly influence drug pricing.
  • Consumer Adherence: High drug prices can lead to non-adherence, affecting public health.

FAQs

Q: What does the NDC 54436-0112 represent? A: The NDC 54436-0112 is a unique identifier for a specific drug product, including its labeler, product, and package details.

Q: Why are prescription drug prices in the U.S. so high compared to other countries? A: Several factors contribute to this, including supply chain dynamics, regulatory differences, and the lack of price controls in the U.S.[3].

Q: How often do drug establishments need to update their drug listing data? A: Drug establishments must update their drug listing data in June and December of each year[4].

Q: What is the impact of high drug prices on consumer behavior? A: High drug prices can lead to non-adherence to medication regimens, with consumers either not filling their prescriptions or altering their dosage to save costs[2].

Q: Are there any proposed changes to the NDC format? A: Yes, the FDA has proposed updating the NDC format to a single 12-digit format to minimize confusion and medication errors[5].

Sources

  1. FDA - National Drug Code Directory
  2. Oregon Drug Price Transparency Program - Annual Report 2022
  3. ASPE - International Prescription Drug Price Comparisons: Estimates Using IQVIA MIDAS Data
  4. FDA - National Drug Code Database Background Information
  5. FDA - Future Format of the National Drug Code

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.